X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 5c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge